Free tool
FAERS Monitor: Jentadueto Xr
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208026 or its brand name (Jentadueto Xr, Linagliptin, Metformin Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
67
Serious
26
39% of reports
Hospitalization
12
Death reported
3
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- blood glucose increased7
- weight decreased6
- diarrhoea5
- malaise4
- pancreatitis4
- tremor3
- abdominal pain upper2
- asthenia2
- blood glucose abnormal2
- confusional state2
- death2
- decreased appetite2
- dental caries2
- diabetes mellitus2
- dizziness2
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2017 | 3 |
| 2018 | 12 |
| 2019 | 5 |
| 2020 | 16 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 5 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,092 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dental caries | 2 | 56.8 | 14.5 | 61 |
| blood glucose abnormal | 2 | 34.0 | 8.7 | 35 |
| pancreatitisSignal | 4 | 23.8 | 9.2 | 66 |
| blood glucose increasedSignal | 7 | 11.7 | 5.8 | 59 |
| diabetes mellitus | 2 | 8.2 | 2.1 | 7 |
| weight decreasedSignal | 6 | 6.7 | 3.1 | 24 |
| tremorSignal | 3 | 5.7 | 1.9 | 7 |
| confusional state | 2 | 3.9 | 1.0 | 2 |
| abdominal pain upper | 2 | 3.0 | 0.8 | 1 |
| malaise | 4 | 2.9 | 1.1 | 3 |
| decreased appetite | 2 | 2.7 | 0.7 | 1 |
| diarrhoea | 5 | 2.4 | 1.0 | 3 |
| asthenia | 2 | 1.7 | 0.4 | 0 |
| dizziness | 2 | 1.3 | 0.3 | 0 |
| death | 2 | 0.7 | 0.2 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.